XT
CUE icon

XTX Topco’s Cue Biopharma CUE Stock Holding History

XTX Topco’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.48K Buy
+504
New +$4.7K ﹤0.01% 3762
2025
Q4 		– Sell
-491
Closed -$10.6K – 3398
2025
Q3 		$10.6K Sell
491
-259
-35% -$6.08K ﹤0.01% 2438
2025
Q2 		$15.3K Sell
750
-148
-16% -$3.16K ﹤0.01% 2205
2025
Q1 		$24.5K Sell
898
-668
-43% -$24.8K ﹤0.01% 2106
2024
Q4 		$51.2K Buy
1,566
+644
+70% +$24.2K ﹤0.01% 1889
2024
Q3 		$20.9K Buy
+922
New +$20K ﹤0.01% 1836
2024
Q1 		– Sell
-510
Closed -$40.4K – 1922
2023
Q4 		$40.4K Sell
510
-1,266
-71% -$90.5K 0.01% 1269
2023
Q3 		$123K Buy
+1,776
New +$173K 0.02% 1154
2022
Q4 		– Sell
-915
Closed -$61K – 1198
2022
Q3 		$61K Sell
915
-380
-29% -$32.7K 0.02% 1007
2022
Q2 		$97K Buy
1,295
+118
+10% +$13.8K 0.04% 653
2022
Q1 		$172K Buy
+1,177
New +$250K 0.08% 442

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return

XTX Topco's CUE Position: Q1 2026 in Review

XTX Topco opened a new position in Cue Biopharma (CUE) in Q1 2026: 504 shares worth $3.48K. The stake represents ﹤0.01% of the portfolio and ranks #3762 among its holdings. This is a return to the name: XTX Topco previously reported a position in CUE as recently as Q3 2025.

XTX Topco first reported a position in CUE in Q1 2022 and has held it in 11 quarters since. The position peaked at $172K in Q1 2022. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • XTX Topco held 504 shares of Cue Biopharma worth $3.48K as of Q1 2026.
  • Cue Biopharma was a new XTX Topco position in Q1 2026.
  • Cue Biopharma made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3762 holding.
  • XTX Topco first reported a position in Cue Biopharma in Q1 2022 and has held it in 11 quarters since.
  • XTX Topco's Cue Biopharma position peaked at $172K in Q1 2022.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.